Molecular cloning and expression of a novel cytochrome P450 from Turkey liver with aflatoxin B1 oxidizing activity

Chemical Research in Toxicology

Volumn 19, Issue 1, 2006, Pages 30-37

  Yip, Shirley S M ^a   Coulombe Jr , Roger A ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1A5; HEMOPROTEIN; METHOXYRESORUFIN; RESORUFIN DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CATALYSIS; CHICKEN; CONTROLLED STUDY; DEALKYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; HUMAN; LIVER; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; POULTRY; PREDICTION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; RAT; TOXICITY; TURKEY (BIRD);

AFLATOXIN B1; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CLONING, MOLECULAR; ESCHERICHIA COLI; LIVER; MALE; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; RECOMBINANT PROTEINS; TURKEYS;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA; MELEAGRIS GALLOPAVO;

EID: 31844452263     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050233+     Document Type: Article

References (37)

1. Parikh, A., Gillam, E. M., and Guengerich, F. P. (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784-788.
2. Guengerich, F. P., Johnson, W. W., Ueng, Y. F., Yamazaki, H., and Shimada, T. (1996) Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ. Health Perspect. 104 (Suppl. 3), 557-562.
3. Coulombe, R. A., Jr. (1993) Biological action of mycotoxins. J. Dairy Sci. 76, 880-891.
4. Asao, T., Buechi, G., Abdel-Kader, M. M., Chang, S. B., Wick, E. L., and Wogan, G. N. (1965) The structures of aflatoxins B and G. J. Am. Chem. Soc. 87, 882-886.
5. Van Vleet, T. R., Mace, K., and Coulombe, R. A., Jr. (2002) Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4. Cancer Res. 62, 105-112.
6. Van Vleet, T. R., Klein, P. J., and Coulombe, R. A., Jr. (2002) Metabolism and cytotoxicity of aflatoxin B1 in cytochrome p-450-expressing human lung cells. J. Toxicol. Environ. Health A 65, 853-867.
7. Kelly, J. D., Eaton, D. L., Guengerich, F. P., and Coulombe, R. A., Jr. (1997) Aflatoxin B1 activation in human lung. Toxicol. Appl. Pharmacol. 144, 88-95.
8. Gallagher, E. P., Kunze, K. L., Stapleton, P. L., and Eaton, D. L. (1996) The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 141, 595-606.
9. Klein, P. J., Van Vleet, T. R., Hall, J. O., and Coulombe, R. A., Jr. (2002) Dietary butylated hydroxytoluene protects against aflatoxicosis in turkeys. Toxicol. Appl. Pharmacol. 182, 11-19.
10. Klein, P. J., Van Vleet, T. R., Hall, J. O., and Coulombe, R. A., Jr. (2002) Biochemical factors underlying the age-related sensitivity of turkeys to aflatoxin B1. Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol. 132, 193-201.
11. Klein, P. J., Buckner, R., Kelly, J., and Coulombe, R. A., Jr. (2000) Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B(1). Toxicol. Appl. Pharmacol. 165, 45-52.
12. Sandhu, P., Guo, Z., Baba, T., Martin, M. V., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys. 309, 168-177.
13. Gillam, E. M., Guo, Z., Martin, M. V., Jenkins, C. M., and Guengerich, F. P. (1995) Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization. Arch. Biochem. Biophys. 319, 540-550.
14. Shimada, T., Wunsch, R. M., Hanna, I. H., Sutter, T. R., Guengerich, F. P., and Gillam, E. M. (1998) Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch. Biochem. Biophys. 357, 111-120.
15. Barnes, H. J., Arlotto, M. P., and Waterman, M. R. (1991) Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 88, 5597-5601.
16. Jenkins, C. M., Pikuleva, I., and Waterman, M. R. (1998) Expression of eukaryotic cytochrome P450 in E. coli. In Cytochrome P450 Protocols (Phillips, I. R., and Shephard, E. A., Eds.) Vol. 107, pp 181-193, Humana Press, Totowa, NJ.
17. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239, 2379-2385.
18. Guengerich, F. P., Martin, M. V., Guo, Z., and Chun, Y. J. (1996) Purification of functional recombinant P450s from bacteria. Methods Enzymol. 272, 35-44.
19. Ramsdell, H. S., and Eaton, D. L. (1990) Species susceptibility to aflatoxin B1 carcinogenesis: Comparative kinetics of microsomal biotransformation. Cancer Res. 50, 615-620.
20. Chang, T. K. H., and Waxman, D. J. (1998) Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate. In Cytochrome P450 Protocols (Phillips, I. R., and Shephard, E. A., Eds.) Vol. 107, pp 103-109, Humana Press, Totowa, NJ.
21. Lewis, D. F. (2001) Guide to Cytochromes P450 Structure and Function, Taylor & Francis Ltd., London, United Kingdom.
22. Strobel, H. W., and Dignam, J. D. (1978) Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol. 52, 89-96.
23. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
24. Gilday, D., Gannon, M., Yutzey, K., Bader, D., and Rifkind, A. B. (1996) Molecular cloning and expression of two novel avian cytochrome P450 1A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 271, 33054-33059.
25. Sabatini, D. D., Kreibich, G., Morimoto, T., and Adesnik, M. (1982) Mechanisms for the incorporation of proteins in membranes and organelles. J. Cell Biol. 92, 1-22.
26. Guo, Z., Gillam, E. M., Ohmori, S., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A1 in Escherichia coli: Effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys. 312, 436-446.
27. Gillam, E. M., and Guengerich, F. P. (2001) Exploiting the versatility of human cytochrome P450 enzymes: The promise of blue roses from biotechnology. IUBMB Life 52, 271-277.
28. Raney, K. D., Meyer, D. J., Ketterer, B., Harris, T. M., and Guengerich, F. P. (1992) Glutathione conjugation of aflatoxin B1 exo- and endoepoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5, 470-478.
29. Black, S. D., and Coon, M. J. (1987) P-450 cytochromes: structure and function. In Advances in Enzymology and Related Areas of Molecular Biology (Meister, A., Ed.) Vol. 60, pp 35-87, John Wiley & Sons, Hoboken, NJ.
30. Estabrook, R. W., Franklin, M. R., Cohen, B., Shigamatzu, A., and Hildebrandt, A. G. (1971) Biochemical and genetic factors influencing drug metabolism. Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control. Metabolism 20, 187-199.
31. Shephard, E. A., Phillips, I. R., Bayney, R. M., Pike, S. F., and Rabin, B. R. (1983) Quantification of NADPH:cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique. Biochem. J. 211, 333-340.
32. Murataliev, M. B., Feyereisen, R., and Walker, F. A. (2004) Electron transfer by diflavin reductases. Biochim. Biophys. Acta 1698, 1-26.
33. Hasselberg, L., Grosvik, B. E., Goksoyr, A., and Celander, M. C. (2005) Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comput. Hepatol. 4, 2.
34. Eaton, D. L., and Gallagher, E. P. (1994) Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34, 135-172.
35. Rice, D. W., and Hsieh, D. P. H. (1982) Aflatoxin M1: In vitro preparation and comparative in vitro metabolism versus aflatoxin B1 in the rat and mouse. Res. Commun. Chem. Pathol. Pharmacol. 35, 467-490.
36. Shibahara, T., Ogawa, H. I., Ryo, H., and Fujikawa, K. (1995) DNA-damaging potency and genotoxicity of aflatoxin M1 in somatic cells in vivo of Drosophila melanogaster. Mutagenesis 10, 161-164.
37. Neal, G. E., Eaton, D. L., Judah, D. J., and Verma, A. (1998) Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems. Toxicol. Appl. Pharmacol. 151, 152-158.